Cathay Joins Sinovation to Treat Skin Conditions
23 Dec 2025
US$ 20.00
Cathay Capital was party to the near Rmb300 m (US$42.6 m) pre-IPO funding round of Sinomune Pharmaceutical Co Ltd ......
Related Publications
The data breach that exposed personal and contact details of 33.7 million customers of the NYSE-listed Coupang Inc...
Crescent Capital Partners, via its Fund VII, has agreed to acquire Billi for £110 m (US$148 m). Billi is owned by the...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.